Skip to main content
Journal of Virology logoLink to Journal of Virology
. 1993 Mar;67(3):1538–1544. doi: 10.1128/jvi.67.3.1538-1544.1993

Vaccinia virus-specific CD8+ cytotoxic T lymphocytes in humans.

W E Demkowicz Jr 1, F A Ennis 1
PMCID: PMC237524  PMID: 8437229

Abstract

Stimulation of human vaccinia virus immune peripheral blood mononuclear cells in vitro from vaccinia virus-immune donors with live vaccinia virus-infected autologous cells generated vaccinia virus-specific cytotoxic T lymphocytes (CTL) capable of lysing vaccinia virus-infected cells. We generated vaccinia virus-specific CD8+ clones and CD4+ CTL lines by limiting dilution from two donors by using peripheral blood mononuclear cells obtained 2 months or 4 years postrevaccination with vaccinia virus. These results demonstrate that vaccinia virus-specific CTL are generated as a result of immunization of humans with vaccinia virus and that both CD8(+)- and CD4(+)-specific T cells are maintained as memory cells.

Full text

PDF
1538

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennink J. R., Yewdell J. W. Recombinant vaccinia viruses as vectors for studying T lymphocyte specificity and function. Curr Top Microbiol Immunol. 1990;163:153–184. doi: 10.1007/978-3-642-75605-4_6. [DOI] [PubMed] [Google Scholar]
  2. Buller R. M., Palumbo G. J. Poxvirus pathogenesis. Microbiol Rev. 1991 Mar;55(1):80–122. doi: 10.1128/mr.55.1.80-122.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Byrne J. A., Oldstone M. B. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J Virol. 1984 Sep;51(3):682–686. doi: 10.1128/jvi.51.3.682-686.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cooney E. L., Collier A. C., Greenberg P. D., Coombs R. W., Zarling J., Arditti D. E., Hoffman M. C., Hu S. L., Corey L. Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein. Lancet. 1991 Mar 9;337(8741):567–572. doi: 10.1016/0140-6736(91)91636-9. [DOI] [PubMed] [Google Scholar]
  5. Demkowicz W. E., Maa J. S., Esteban M. Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans. J Virol. 1992 Jan;66(1):386–398. doi: 10.1128/jvi.66.1.386-398.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Doherty P. C., Biddison W. E., Bennink J. R., Knowles B. B. Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype. J Exp Med. 1978 Aug 1;148(2):534–543. doi: 10.1084/jem.148.2.534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Doherty P. C., Korngold R. Characteristics of poxvirus-induced meningitis: virus-specific and non-specific cytotoxic effectors in the inflammatory exudate. Scand J Immunol. 1983 Jul;18(1):1–7. doi: 10.1111/j.1365-3083.1983.tb00828.x. [DOI] [PubMed] [Google Scholar]
  8. Graham S., Green C. P., Mason P. D., Borysiewicz L. K. Human cytotoxic T cell responses to vaccinia virus vaccination. J Gen Virol. 1991 May;72(Pt 5):1183–1186. doi: 10.1099/0022-1317-72-5-1183. [DOI] [PubMed] [Google Scholar]
  9. Issekutz T. B. Kinetics of cytotoxic lymphocytes in efferent lymph from single lymph nodes following immunization with vaccinia virus. Clin Exp Immunol. 1984 Jun;56(3):515–523. [PMC free article] [PubMed] [Google Scholar]
  10. KEMPE C. H. Studies smallpox and complications of smallpox vaccination. Pediatrics. 1960 Aug;26:176–189. [PubMed] [Google Scholar]
  11. Kuwano K., Tamura M., Ennis F. A. Cross-reactive protection against influenza A virus infections by an NS1-specific CTL clone. Virology. 1990 Sep;178(1):174–179. doi: 10.1016/0042-6822(90)90391-4. [DOI] [PubMed] [Google Scholar]
  12. Littaua R. A., Takeda A., Cruz J., Ennis F. A. Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones. J Virol. 1992 Apr;66(4):2274–2280. doi: 10.1128/jvi.66.4.2274-2280.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mallon V. R., Domber E. A., Holowczak J. A. Vaccinia virus proteins on the plasma membranes of infected cells. II. Expression of viral antigens and killing of infected cells by vaccinia virus-specific cytotoxic T cells. Virology. 1985 Aug;145(1):1–23. doi: 10.1016/0042-6822(85)90197-7. [DOI] [PubMed] [Google Scholar]
  14. Mizuochi T., Hügin A. W., Morse H. C., 3rd, Singer A., Buller R. M. Role of lymphokine-secreting CD8+ T cells in cytotoxic T lymphocyte responses against vaccinia virus. J Immunol. 1989 Jan 1;142(1):270–273. [PubMed] [Google Scholar]
  15. Morrison L. A., Braciale V. L., Braciale T. J. Antigen form influences induction and frequency of influenza-specific class I and class II MHC-restricted cytolytic T lymphocytes. J Immunol. 1988 Jul 15;141(2):363–368. [PubMed] [Google Scholar]
  16. Moss B. Vaccinia virus: a tool for research and vaccine development. Science. 1991 Jun 21;252(5013):1662–1667. doi: 10.1126/science.2047875. [DOI] [PubMed] [Google Scholar]
  17. O'CONNELL C. J., KARZON D. T., BARRON A. L., PLAUT M. E., ALI V. M. PROGRESSIVE VACCINIA WITH NORMAL ANTIBODIES. A CASE POSSIBLY DUE TO DEFICIENT CELLULAR IMMUNITY. Ann Intern Med. 1964 Feb;60:282–289. doi: 10.7326/0003-4819-60-2-282. [DOI] [PubMed] [Google Scholar]
  18. PINCUS W. B., FLICK J. A. The role of hypersensitivity in the pathogenesis of vaccinia virus infection in humans. J Pediatr. 1963 Jan;62:57–62. doi: 10.1016/s0022-3476(63)80071-2. [DOI] [PubMed] [Google Scholar]
  19. Perrin L. H., Zinkernagel R. M., Oldstone M. B. Immune response in humans after vaccination with vaccinia virus: generation of a virus-specific cytotoxic activity by human peripheral lymphocytes. J Exp Med. 1977 Oct 1;146(4):949–969. doi: 10.1084/jem.146.4.949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Shen L., Chen Z. W., Miller M. D., Stallard V., Mazzara G. P., Panicali D. L., Letvin N. L. Recombinant virus vaccine-induced SIV-specific CD8+ cytotoxic T lymphocytes. Science. 1991 Apr 19;252(5004):440–443. doi: 10.1126/science.1708168. [DOI] [PubMed] [Google Scholar]
  21. Sly W. S., Sekhon G. S., Kennett R., Bodmer W. F., Bodmer J. Permanent lymphoid lines from genetically marked lymphocytes: success with lymphocytes recovered from frozen storage. Tissue Antigens. 1976 Mar;7(3):165–172. doi: 10.1111/j.1399-0039.1976.tb01047.x. [DOI] [PubMed] [Google Scholar]
  22. Stitz L., Zinkernagel R., Balch C. M., Bolhuis R. L., Balner H. Immune response against vaccinia virus in rhesus monkeys: no evidence for primary MHC-restricted cytolytic T cells. Exp Cell Biol. 1984;52(4):237–250. doi: 10.1159/000163267. [DOI] [PubMed] [Google Scholar]
  23. Tartaglia J., Pincus S., Paoletti E. Poxvirus-based vectors as vaccine candidates. Crit Rev Immunol. 1990;10(1):13–30. [PubMed] [Google Scholar]
  24. Zarling J. M., Eichberg J. W., Moran P. A., McClure J., Sridhar P., Hu S. L. Proliferative and cytotoxic T cells to AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins. J Immunol. 1987 Aug 15;139(4):988–990. [PubMed] [Google Scholar]
  25. Zinkernagel R. M., Althage A., Jensen F. C. Cell-mediated immune response to lymphocytic choriomeningitis and vaccinia virus in rats. J Immunol. 1977 Oct;119(4):1242–1247. [PubMed] [Google Scholar]
  26. van Binnendijk R. S., Poelen M. C., de Vries P., Voorma H. O., Osterhaus A. D., Uytdehaag F. G. Measles virus-specific human T cell clones. Characterization of specificity and function of CD4+ helper/cytotoxic and CD8+ cytotoxic T cell clones. J Immunol. 1989 Apr 15;142(8):2847–2854. [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES